ACRO Biomedical Co., Ltd.

ACRO Biomedical Co., Ltd. is a Taiwan-based tissue engineering and regenerative medicine company founded in 2014 by Dr. Dar-Jen Hsieh and a team of scientists and physicians. The company specializes in developing acellular biomaterial medical devices using proprietary supercritical CO₂ extraction technology to decellularize animal tissues while preserving intact collagen scaffolds. These biocompatible, sterile collagen matrices serve as regenerative platforms across multiple clinical disciplines including wound care, orthopedic repair (bone grafts, cartilage regeneration), dental reconstruction (membranes, bone augmentation), corneal regeneration, aesthetic microsurgery, and cardiovascular/neural tissue engineering. ACRO's product portfolio includes acellular dermal matrices, collagen-based corneal implants, bone grafts, and tissue fillers. The company holds TFDA approval and has received national recognition for innovation in regenerative medicine, positioning itself as a leader in high-end biomaterial solutions for tissue regeneration.